Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Completed 4 Unknown 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 23 Gastrointestinal 8 Endocrine 8 Sarcoma 7 Thoracic 5 Head & Neck 5 NET 4 Gynecologic 3 Dermatologic 2 CNS 2 Breast 2 Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 17 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Paclitaxel 7 Biopsy 7 Nivolumab 6 atezolizumab 5 Surveys and Questionnaires 4 Standard of Care 4 Radiosurgery 4 Practice Guidelines as Topic 4 Pemetrexed 4 Oxaliplatin 4 Cyclophosphamide 4 Carboplatin 4 osimertinib 3 niraparib 3 durvalumab 3 cemiplimab 3 avelumab 3 Radiotherapy 3 Radiation 3 Leucovorin 3 Irinotecan 3 Ipilimumab 3 Interviews as Topic 3 Fluorouracil 3 trastuzumab deruxtecan 2 trametinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × cabozantinib × Tumor-Agnostic × Clear all

NCT03768063 2026-04-28

IMbrella B

Hoffmann-La Roche

Phase 3 Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡